Photodynamic Therapy in Ocular Oncology
AbstractAlthough introduced for the treatment of maculopathies, photodynamic therapy (PDT) is now largely used in some eye cancers treatment. The selective tissue damage with PDT is achieved by sequestration of the photosensitizer in the target tissue and focal activation of the photosensitizer by low energy directed light. In this way, it is possible to achieve the destruction of the tumor tissue by safeguarding the surrounding healthy structures. Our study describes the clinical uses and efficacy of photodynamic therapy in ocular oncology. View Full-Text
Share & Cite This Article
Blasi, M.A.; Pagliara, M.M.; Lanza, A.; Sammarco, M.G.; Caputo, C.G.; Grimaldi, G.; Scupola, A. Photodynamic Therapy in Ocular Oncology. Biomedicines 2018, 6, 17.
Blasi MA, Pagliara MM, Lanza A, Sammarco MG, Caputo CG, Grimaldi G, Scupola A. Photodynamic Therapy in Ocular Oncology. Biomedicines. 2018; 6(1):17.Chicago/Turabian Style
Blasi, Maria A.; Pagliara, Monica M.; Lanza, Angela; Sammarco, Maria G.; Caputo, Carmela G.; Grimaldi, Gabriela; Scupola, Andrea. 2018. "Photodynamic Therapy in Ocular Oncology." Biomedicines 6, no. 1: 17.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.